CASIPP
November 2-4
Santa Barbara
SPR will be on hand as exhibitors and will also support a didactic cadaver lab.
View website.
SPR Therapeutics Awarded $10M From U.S. Department of Defense
Latest awards will advance further research and development of the SPRINT PNS System for chronic and acute pain
CLEVELAND, Oct. 02, 2018 (GLOBE NEWSWIRE) — SPR Therapeutics, Inc., a leader in …
SPR Therapeutics Announces First Use of SPRINT extensa Dual-lead Peripheral Nerve Stimulation System to Treat Low Back Pain
SPRINT offers a non-opioid, non-ablative and non-surgical low back pain treatment alternative
CLEVELAND, Sept. 25, 2018 (GLOBE NEWSWIRE) — SPR Therapeutics, Inc., a leader in neurostimulation …
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
SPRINT® is the First and Only Dual Lead Capable PNS Platform
Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy
Cleveland, Ohio- August 16, 2018 – SPR …
